Mus musculus
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA148601 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Genome-wide maps of 5hmC/5mC state in pluripotent and (T-)iPS induction cells.
| PRJNA171321 | ENA
Project description:Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
| PRJNA113703 | ENA
Project description:Gene expression in pluripotent and TSKM-iPS induction cells.
| PRJNA171322 | ENA
Project description:Genome-wide maps of chromatin state in mouse erythroid cells.
| PRJNA141733 | ENA
Project description:Genome-wide maps of H3K27 state in transfected NIH3T3 cells.
| PRJNA359491 | ENA
Project description:Genome-wide maps of chromatin state in interferon stimulated cells
| PRJNA351859 | ENA
Project description:We report here differentiated enrichment of H3K4me1 at Lsh WT and KO mouse embryonic fibroblasts (MEFs). We found a subset of differentially enriched H3K4me1 regions in Lsh KO MEFs, and they clustered at neuronal lineage genes and overlapping with known cis-regulatory elements present in brain tissue. Reprogramming of Lsh?/? MEFs into induced pluripotent stem (iPS) cells leads to increased neuronal lineage gene expression of premarked genes and enhanced differentiation potential of Lsh?/? iPS cells toward the neuronal lineage pathway compared with WT iPS cells in vitro and in vivo. The state of H3K4me1 enrichment is partially maintained in Lsh?/? iPS cells, suggesting the regions are preserved as potential enhancers. Genome-wide maps of H3K4me1 in Lsh WT and KO primary MEFs.
2014-03-25 | E-GEOD-56151 | biostudies-arrayexpress
Project description:Genome-wide maps of chromatin state in Germinal Center B cells.
| PRJNA219348 | ENA
Project description:Ectopic expression of four transcription factors including Oct4, Sox2, Klf4 and c-Myc in differentiated fibroblast cells could reset the cell fate of fibroblast cells to pluripotent state. Subsequently, fully pluripotency of these so-called induced pluripotent stem cells (iPSCs) has been demonstrated as viable mice could be generated autonomously from iPS cells through tetraploid blastocyst complementation. Moreover, the generation of human and patient-specific iPS cells have raised the possibility of utilizing iPS cells clinically. However, the utilization of c-Myc in iPS cells induction greatly increased the incidence of tumorigenecity in the iPS-chimeric mice and also might hinder the clinical application of human iPS cells in the future. Fortunately, c-Myc has been recently found dispensable for iPS induction even though the iPS induction efficiency is greatly reduced in the absence of c-Myc. However, it remains unknown if these three factors-induced iPS cells are fully pluripotent. In the present study, we have successfully demonstrated that 3-factor iPS cells could also be fully pluripotent as viable mice could be generated from 3-factor iPS cells autonomously via tetraploid complementation and moreover, our data indicated that the pluripotency regulatory mechanism in 3-factor iPS cells might be distinct from 4-factor iPS cells.
2010-10-19 | GSE24046 | GEO